Expression of the gene encoding the matrix gla protein by mature osteoblasts in human fracture non-unions

Citation
Dm. Lawton et al., Expression of the gene encoding the matrix gla protein by mature osteoblasts in human fracture non-unions, J CL PATH-M, 52(2), 1999, pp. 92-96
Citations number
31
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Medical Research Diagnosis & Treatment
Journal title
JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY
ISSN journal
13668714 → ACNP
Volume
52
Issue
2
Year of publication
1999
Pages
92 - 96
Database
ISI
SICI code
1366-8714(199904)52:2<92:EOTGET>2.0.ZU;2-#
Abstract
Background-Osteoblast phenotypic abnormality, namely the expression of coll agen type III, has been shown previously in fracture non-union woven bone. Aims-To investigate osteoblasts from fracture non-unions for evidence of ge ne expression of non-collagenous bone matrix proteins that have been implic ated in mineralisation, namely matrix gla protein (MGP), osteonectin, osteo pontin, and osteocalcin. MGP is a consistent component of bone matrix, but there are no reports of osteoblasts in the skeleton expressing the gene for MGP, and the site of synthesis of skeletal MGP (perhaps the liver) has yet to be determined. Methods-Biopsies from normally healing human fractures and non-unions were examined by means of in situ hybridisation, using S-35 labelled probes and autoradiography to disclose levels of gene expression. Results-In normally healing fractures, mature osteoblasts on woven bone wer e negative for MGP mRNA, but positive for osteonectin, osteopontin, and ost eocalcin mRNA molecules. In non-unions, osteoblasts displayed a novel pheno type: they were positive for MGP mRNA, in addition to osteonectin, osteopon tin, and osteocalcin mRNA molecules. Conclusions-Mature osteoblasts in slowly healing fractures have an unusual phenotype: they express the gene encoding MGP, which indicates that control of osteoblast gene expression in non-unions is likely to be abnormal. This might be of importance in the pathogenesis of non-uniting human fractures, and is of current interest given the emerging status of MGP as an inhibito r of mineralisation.